SCHEMBL4058531

SCHEMBL4058531

CNC(C)C(C)CC=Cc1cccnc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 3/20 0.74
CHRNA4 P43681 3/20 0.74
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
CHRNB4 P30926 1/20 0.56
CHRNA3 P32297 1/20 0.56
CHRNA7 P36544 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
ALOX15 P16050 1/20 0.56
CYP2C19 P33261 1/20 0.56
CYP11B1 P15538 1/20 0.45
CYP11B2 P19099 1/20 0.45
ALOX5 P09917 2/20 0.43
TBXAS1 P24557 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
KDM4E B2RXH2 1/20 0.41
JUN P05412 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4058522 1.00 CHRNB2 (0.74) CHRNB2CHRNA4MEN1KMT2ACHRNB4
SCHEMBL620178 0.85 CHRNB2 (1.00) CHRNB2CHRNA4MEN1KMT2ACHRNB4
SCHEMBL2472109 0.85 CHRNB2 (1.00) CHRNB2CHRNA4MEN1KMT2ACHRNB4
SCHEMBL620444 0.85 CHRNB2 (1.00) CHRNB2CHRNA4MEN1KMT2ACHRNB4
SCHEMBL620443 0.85 CHRNB2 (1.00) CHRNB2CHRNA4MEN1KMT2ACHRNB4
SCHEMBL2472105 0.85 CHRNB2 (1.00) CHRNB2CHRNA4MEN1KMT2ACHRNB4
SCHEMBL3011080 0.85 CHRNB2 (1.00) CHRNB2CHRNA4MEN1KMT2ACHRNB4
SCHEMBL620179 0.85 CHRNB2 (1.00) CHRNB2CHRNA4MEN1KMT2ACHRNB4
SCHEMBL3025719 0.82 CHRNB2 (0.68) CHRNB2CHRNA4MEN1KMT2ACHRNB4
SCHEMBL3025722 0.82 CHRNB2 (0.68) CHRNB2CHRNA4MEN1KMT2ACHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900200-B9 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS TARGACEPT INC (US) 2009-10-21 EP disclosed
EP-0900200-B1 PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS TARGACEPT INC (US) 2008-12-03 EP disclosed